Emmet McCormack

4.8k total citations · 2 hit papers
90 papers, 3.1k citations indexed

About

Emmet McCormack is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Emmet McCormack has authored 90 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 36 papers in Oncology and 18 papers in Biomedical Engineering. Recurrent topics in Emmet McCormack's work include Cancer Cells and Metastasis (15 papers), Acute Myeloid Leukemia Research (15 papers) and Histone Deacetylase Inhibitors Research (13 papers). Emmet McCormack is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Acute Myeloid Leukemia Research (15 papers) and Histone Deacetylase Inhibitors Research (13 papers). Emmet McCormack collaborates with scholars based in Norway, United States and Netherlands. Emmet McCormack's co-authors include Bjørn Tore Gjertsen, Øystein Bruserud, Spiros Kotopoulis, Odd Helge Gilja, David Micklem, Mihaela Popa, James B. Lorens, Rolf Bjerkvig, Georg Dimcevski and Michiel Postema and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emmet McCormack

86 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation

2009 497 citations Gro Vatne Røsland, Agnete Svendsen et al. Cancer Research profile →
A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

2016 359 citations Georg Dimcevski, Spiros Kotopoulis et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Emmet McCormack

Since Specialization

Citations

This map shows the geographic impact of Emmet McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmet McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmet McCormack more than expected).

Fields of papers citing papers by Emmet McCormack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmet McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmet McCormack. The network helps show where Emmet McCormack may publish in the future.

Co-authorship network of co-authors of Emmet McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of Emmet McCormack. A scholar is included among the top collaborators of Emmet McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmet McCormack. Emmet McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐ CD 73/anti‐ PD ‐ L 1 immunotherapy in arm A of the NSGO ‐ OV ‐ UMB1 / ENGOT ‐ OV 30 trial 2025 ·Molecular Oncology ·(unknown), Annika Auranen, (unknown), René dePont Christensen, Liv Cecilie Vestrheim Thomsen, (unknown), Emmet McCormack, Johanna Mäenpää, (unknown), (unknown), Mansoor Raza Mirza, Line Bjørge	0
2	Localized paclitaxel delivery using a novel hyaluronic acid-coated fibrous carrier produced via needle-less electrospinning 2025 ·Journal of Industrial Textiles ·Daniela Lubasová, (unknown), Emmet McCormack	1
3	AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis 2025 ·Cancer Research ·(unknown), (unknown), Pascal Gélébart, Emmet McCormack	0
4	Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy 2024 ·STAR Protocols ·(unknown), (unknown), Mihaela Popa, (unknown), (unknown), Else Marit Inderberg, Sébastien Wälchli, Pascal Gélébart, Emmet McCormack	0
5	Vididencel, a Leukemia-Derived Dendritic Cell Vaccine, Acts Synergistically with Azacitidine/Venetoclax Treatment in a Preclinical AML Model 2024 ·Blood ·(unknown), (unknown), Jorn Kaspers, Mihaela Popa, Alex Karlsson‐Parra, Erik H. Manting, (unknown), Bjørn Tore Gjertsen, Emmet McCormack, Satwinder Singh	1
6	Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys 2021 ·Pharmaceutics ·Øystein Eikrem, Spiros Kotopoulis, Mihaela Popa, (unknown), (unknown), Sabine Leh, Lea Landolt, Janka Bábíčková, Oddrun Anita Gudbrandsen, Odd Helge Gilja, Bettina Riedel, Jan Schjøtt, Emmet McCormack, Hans‐Peter Marti	4
7	Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods 2021 ·Cancers ·(unknown), Liv Cecilie Vestrheim Thomsen, (unknown), Tamim Abdelaal, (unknown), Jørn Skavland, Geir Bredholt, Bjørn Tore Gjertsen, Emmet McCormack, Line Bjørge	6
8	DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance 2021 ·iScience ·Juan Zhang, (unknown), Mihaela Popa, (unknown), Marcus J.G.W. Ladds, (unknown), Jacob Grünler, Marie Arsenian‐Henriksson, Emmet McCormack, Martı́n E. Rottenberg, Sergiu‐Bogdan Catrina, Sonia Laı́n, Suhas Darekar	15
9	Repurposing ¹⁸F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy 2021 ·Theranostics ·Gorka Ruíz de Garibay, (unknown), (unknown), (unknown), Mihaela Popa, Ben Davidson, (unknown), Cecilie Brekke Rygh, Heidi Espedal, (unknown), Bengt Erik Haug, Emmet McCormack	8
10	Nanodiamond modified copolymer scaffolds affects tumour progression of early neoplastic oral keratinocytes 2016 ·Biomaterials ·Salwa Suliman, Kamal Mustafa, Anke Krueger, Doris Steinmüller‐Nethl, Anna Finne‐Wistrand, (unknown), (unknown), Yang Sun, Himalaya Parajuli, Thilo Waag, Joachim Nickel, Anne Christine Johannessen, Emmet McCormack, Daniela Elena Costea	12
11	A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer breakdown → 2016 ·Journal of Controlled Release ·Georg Dimcevski, Spiros Kotopoulis, Tormod Bjånes, Dag Hoem, Jan Schjøtt, Bjørn Tore Gjertsen, Martin Biermann, Anders Molven, Halfdan Sørbye, Emmet McCormack, Michiel Postema, Odd Helge Gilja	359
12	The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer 2016 ·PLoS ONE ·(unknown), Mihaela Popa, Katharina Bischof, Bjørn Tore Gjertsen, Emmet McCormack, Line Bjørge	31
13	Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling 2013 ·Cancer Research ·Yi Qu, Anne M. Øyan, Runhui Liu, (unknown), Jigang Zhang, Randi Hovland, Mihaela Popa, Xiaojun Liu, Karl A. Brokstad, Ronald Simon, Anders Molven, Biaoyang Lin, Weidong Zhang, Emmet McCormack, Karl‐Henning Kalland, Xisong Ke	61
14	Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines 2013 ·PLoS ONE ·(unknown), (unknown), Line Wergeland, André Sulen, Vibeke Andresen, Jean‐Christophe Bourdon, David Micklem, Emmet McCormack, Bjørn Tore Gjertsen	26
15	Sonoporation-Enhanced Chemotherapy Significantly Reduces Primary Tumour Burden in an Orthotopic Pancreatic Cancer Xenograft 2013 ·Molecular Imaging and Biology ·Spiros Kotopoulis, Anthony Delalande, Mihaela Popa, Veronika Mamaeva, Georg Dimcevski, Odd Helge Gilja, Michiel Postema, Bjørn Tore Gjertsen, Emmet McCormack	109
16	Nitroreductase, a Near-Infrared Reporter Platform for In Vivo Time-Domain Optical Imaging of Metastatic Cancer 2012 ·Cancer Research ·Emmet McCormack, (unknown), Richard M. West, Tina Pavlin, David Micklem, James B. Lorens, Bengt Erik Haug, Michael E. Cooper, Bjørn Tore Gjertsen	37
17	Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid 2012 ·PLoS ONE ·(unknown), Tanima SenGupta, (unknown), Jessica M. Lindvall, Emmet McCormack, Bjørn Tore Gjertsen, Hilde Nilsen	17
18	Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors 2012 ·Cancer Immunology Immunotherapy ·Emmet McCormack, Katherine J. Adams, Namir J. Hassan, (unknown), Nikolai M. Lissin, Malkit Sami, (unknown), (unknown), Bjørn Tore Gjertsen, Deborah Baker, Alex S. Powlesland, Milos Aleksic, Annelise Vuidepot, Olivier Morteau, Deborah H. Sutton, Carl H. June, Michael Kalos, Rebecca Ashfield, Bent K. Jakobsen	80
19	Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation breakdown → 2009 ·Cancer Research ·Gro Vatne Røsland, Agnete Svendsen, Anja Torsvik, (unknown), Emmet McCormack, Heike Immervoll, Josef Mysliwietz, Joerg‐Christian Tonn, Roland Goldbrunner, Per Eystein Lønning, Rolf Bjerkvig, Christian Schichor	497
20	Animal models of acute myelogenous leukaemia – development, application and future perspectives 2005 ·Leukemia ·Emmet McCormack, Øystein Bruserud, Bjørn Tore Gjertsen	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact